Lyell Immunopharma OverviewLyell Immunopharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for LYEL.
Quarterly EBIT
-$1.90M
↑ 96.69% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
$90.58M
↑ 140.47% YoY
Trailing 12 months ending Mar 31, 2026
Lyell Immunopharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for LYEL.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026